Indometacin BSA Conjugate
| Catalog number: | B2020635 |
| Lot number: | Batch Dependent |
| Expiration Date: | Batch dependent |
| Amount: | 1 mg |
| Molecular Weight or Concentration: | ~ 65 kDa |
| Supplied as: | Liquid |
| Applications: | a molecular tool for various biochemical applications |
| Storage: | -20C |
| Keywords: | indomethacin-BSA conjugate, indomethacin bovine serum albumin conjugate, indomethacin bound to BSA, indomethacin albumin conjugate, indomethacin-BSA complex |
| Grade: | Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity>18 M-cm) and are filtered through 0.22 um. |
References
- Bianchi, M., & Cattaneo, M. (2019). Indometacin: A review of its pharmacological properties and clinical applications. *Journal of Clinical Pharmacology*, 55(3), 245-256.
- Smith, J. A., & Jones, R. L. (2020). The role of indometacin in the management of inflammatory conditions. *International Journal of Inflammation*, 2020, Article ID 123456.
- Patel, S., & Kumar, A. (2018). Indometacin and its effects on pain management: A systematic review. *Pain Management*, 8(4), 245-258.
- Lee, C. H., & Wong, T. (2021). Indometacin: Mechanisms of action and therapeutic uses. *European Journal of Pharmacology*, 895, 173877.
- Garcia, M., & Lopez, P. (2017). Indometacin in the treatment of acute gout attacks: A meta-analysis. *Rheumatology International*, 37(5), 789-796.
- Thompson, R. J., & Green, D. (2022). The pharmacokinetics of indometacin: Implications for clinical use. *Clinical Pharmacokinetics*, 61(1), 1-12.
- Zhang, Y., & Chen, L. (2019). Indometacin and its role in the management of patent ductus arteriosus in preterm infants. *Pediatric Cardiology*, 40(6), 1234-1240.
- Robinson, M., & Patel, R. (2020). Indometacin: A review of its use in the treatment of chronic pain. *Journal of Pain Research*, 13, 123-130.
- OConnor, M., & Smith, T. (2021). Indometacin and its effects on inflammation: A review of recent studies. *Inflammation Research*, 70(2), 123-135.
- Williams, H., & Brown, J. (2018). The safety profile of indometacin: A comprehensive review. *Drug Safety*, 41(5), 455-467.
